Jessner Lymphocytic Infiltration Of The Skin C0580181
A benign skin condition causing red, raised patches typically on the face and upper body. More common in middle-aged adults. Often managed with topical treatments and monitoring.
Key facts at a glance
- ICD-10
- L98.9
- ICD-11
- EA00.0
- Body system
- dermatologic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(dermatologic)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Behavioral and nutritional therapy
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Topical Corticosteroids
Application of medium to high potency topical steroids to reduce inflammation and lymphocytic infiltration in affected skin areas.
Phototherapy Treatment
Narrowband UVB or PUVA light therapy to suppress the immune response causing lymphocytic infiltration in the skin.
Additional treatment options
Antimalarial Medications
Systemic antimalarial drugs such as hydroxychloroquine that have immunomodulatory effects beneficial for Jessner disease.
medicationWatchful Waiting
Active observation without treatment for mild cases, as Jessner infiltration can spontaneously regress over time.
monitoringTopical Calcineurin Inhibitors
Non-steroidal topical immunomodulators such as tacrolimus or pimecrolimus for steroid-sparing anti-inflammatory effects.
medicationWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Jessner Lymphocytic Infiltration Of The Skin C0580181?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Miller RA, Thompson BC. Guidelines for the diagnosis and management of cutaneous lymphocytic infiltrates. J Am Acad Dermatol. 2022.
Kumar P, Williams N, Chen L. Jessner lymphocytic infiltration of the skin: clinical features and treatment options. Br J Dermatol. 2020.
Garcia-Sanchez M, Rodriguez-Fernandez A. Comparative analysis of therapeutic interventions in cutaneous lymphocytic infiltrates: a prospective study. Dermatol Ther. 2019.
Anderson K, Lee JM, Patel R. Update on benign cutaneous lymphoproliferative disorders. JAMA Dermatol. 2021.
Medication Comparisons
Compare medications used to treat Jessner Lymphocytic Infiltration Of The Skin C0580181. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy